Auswahl der wissenschaftlichen Literatur zum Thema „Alzhiemer's disease“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Alzhiemer's disease" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Alzhiemer's disease"
Nevins, A., und S. Cohn. „More Audiovisuals on Alzhiemer's Disease“. Gerontologist 25, Nr. 5 (01.10.1985): 551–52. http://dx.doi.org/10.1093/geront/25.5.551a.
Der volle Inhalt der QuelleNevins, A., und H. Rzetelny. „More Audiovisuals on Alzhiemer's Disease“. Gerontologist 25, Nr. 5 (01.10.1985): 552. http://dx.doi.org/10.1093/geront/25.5.552.
Der volle Inhalt der QuelleFontana, Andrea, und Ronald W. Smith. „Alzheimer's Disease Victims: The “Unbecoming” of Self and the Normalization of Competence“. Sociological Perspectives 32, Nr. 1 (März 1989): 35–46. http://dx.doi.org/10.2307/1389006.
Der volle Inhalt der QuelleLiu-Seifert, Hong, Eric Siemers, Karen Price, Baoguang Han, Katherine Selzler, David Henley, Karen Sundell et al. „P2-390: COGNITION IMPAIRMENT PRECEDES AND PREDICTS FUNCTIONAL IMPAIRMENT IN MILD ALZHIEMER's DISEASE“. Alzheimer's & Dementia 10 (Juli 2014): P621. http://dx.doi.org/10.1016/j.jalz.2014.05.1070.
Der volle Inhalt der QuelleRozemuller, J. M., P. Eikelenboom, W. Kamphorst und F. C. Stam. „Lack of evidence for dysfunction of the blood-brain barrier in Alzhiemer's disease: An immunohistochemical study“. Neurobiology of Aging 9 (Januar 1988): 383–91. http://dx.doi.org/10.1016/s0197-4580(88)80085-x.
Der volle Inhalt der QuelleKumari, Rima, Suman Khushwaha und Rohit Gupta. „P1-086: Alzhiemer's disease: Differentiation from other dementias based on quantitative diffusion tensor imaging on 3 Tesla MRI“. Alzheimer's & Dementia 5, Nr. 4S_Part_7 (Juli 2009): P198. http://dx.doi.org/10.1016/j.jalz.2009.04.090.
Der volle Inhalt der QuelleApostol, Marcin I., Ashley Wright, Matthew Graf, Jon Scherrer, Ken Kosik und James Treanor. „P4-156: DISCOVERY OF NOVEL SMALL MOLECULE THERAPEUTICS FOR ALZHIEMER'S DISEASE BY TARGETING STERIC ZIPPERS INVOLVED IN TAU AGGREGATION“. Alzheimer's & Dementia 15 (Juli 2019): P1334. http://dx.doi.org/10.1016/j.jalz.2019.06.3818.
Der volle Inhalt der QuelleSR, SHARUNYA, VIJAYALAKSHMI DESAI, MEENAKSHI SINGH und KUSUMA M. „Survey on Early Detection of Alzhiemer’s Disease Using Capsule Neural Network“. International Journal of Artificial Intelligence 7, Nr. 1 (23.04.2020): 7–12. http://dx.doi.org/10.36079/lamintang.ijai-0701.65.
Der volle Inhalt der QuelleBezprozvanny, I. „Presenilins function as ER calcium leak channels: Implications for Alzhiemer’s disease“. Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology 3, Nr. 3 (September 2009): 301. http://dx.doi.org/10.1134/s199074780903012x.
Der volle Inhalt der QuelleWojtunik-Kulesza, Karolina A., und Monika Waksmundzka- Hajnos. „Natural terpenes as substances with multidirectional biological activities“. Postępy Polskiej Medycyny i Farmacji 6 (08.05.2019): 43–50. http://dx.doi.org/10.5604/01.3001.0013.2320.
Der volle Inhalt der QuelleDissertationen zum Thema "Alzhiemer's disease"
Freer, Rosie. „Molecular origins of tissue vulnerability to aberrant aggregation in protein misfolding diseases“. Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/275420.
Der volle Inhalt der QuellePayne, Magali. „Olfaction, cognition et émotions : liens dans la maladie d'Alzheimer, l'apathie et la COVID-19“. Electronic Thesis or Diss., Université Côte d'Azur, 2022. http://www.theses.fr/2022COAZ6013.
Der volle Inhalt der QuelleIn this thesis we created an olfactory test to measure its usefullness to detect disorders such as Alzheimer's disease or apathy syndrome or COVID-19.First, we collected the opinions of clinicians and the recommendations of experts chemists. We then selected fourteen odors, and we developed a computerized olfactory test that was able to calculate threshold and identification automatically using theses odors. We submitted a Patent for this test named "Olfactory Test for screening Alzheimer's disease ans apathy" (TODA).We cerified the interest ol TODA in everyday care practice in the diagnosis of Alzheimer's disease. Using subjects with Alzheimer's disease and healthy control subjects, both in France and Quebec, the test scores significantly differenciate AD subjects from control subjects. This test allowed cognitive monitoring of patients and highlighted odor identification regardless of culture and pathology.With a population of subjects with Minor Cognitive Disorder, with and without apathy, the results were able to significantly differenciate subjects, in particular, with a social sub-dimension of Critéria of Apathy.With subjects suffering from post-COVID-19 infection we tested with the TODA and in parallel we used the Sniffin' Stick Test, a gold standard, to verify the validity of the TODA results. The TODA also allowed us to highlight the problems identify similar odors. Finally, we also highlighted the interest of using the TODA in the case of suspected associated semantics impairment.The comparison of the TODA scores obtained by AD subjects and COVID-19 subjects showed that there was no difference between the two groups. Only the study of the most significant odors made it possible to differenciate between the two patologies
Buchteile zum Thema "Alzhiemer's disease"
Riesner, Detlev. „Protein Aggregation Associated with alzhiemer and Prion Diseases“. In Springer Series in Chemical Physics, 225–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-59542-4_11.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "Alzhiemer's disease"
Noel, Rebecca L., Alec J. Batts und Elisa E. Konofagou. „Focused Ultrasound-Induced Blood-Brain Barrier Opening Delays the Onset of Alzhiemer's Disease-Associated Pathology in Male and Female 3xTg Mice“. In 2022 IEEE International Ultrasonics Symposium (IUS). IEEE, 2022. http://dx.doi.org/10.1109/ius54386.2022.9957937.
Der volle Inhalt der QuelleShukla, Amar, Rajeev Tiwari und Shamik Tiwari. „Automated Pipeline Preprocessing Techniques for Alzhiemer Disease Detection“. In 2022 10th International Conference on Reliability, Infocom Technologies and Optimization (Trends and Future Directions) (ICRITO). IEEE, 2022. http://dx.doi.org/10.1109/icrito56286.2022.9964957.
Der volle Inhalt der QuelleGangyan, Manu, und Pravir Kumar. „VEGF and its role in the treatment of Diabetes and Alzhiemer’s Disease“. In 2021 Sixth International Conference on Image Information Processing (ICIIP). IEEE, 2021. http://dx.doi.org/10.1109/iciip53038.2021.9702619.
Der volle Inhalt der QuelleLu, Benjamin M., und Abhinav S. Gurram. „revoAD: Revolutionizing Alzhiemer’s Disease Diagnosis through Multimodal Machine Learning for Universal Screening via Speech and Handwriting Patterns“. In 2023 8th International Conference on Intelligent Informatics and Biomedical Sciences (ICIIBMS). IEEE, 2023. http://dx.doi.org/10.1109/iciibms60103.2023.10347810.
Der volle Inhalt der Quelle